The abstract is read at the publisher; the summary is JClub's.
Biological sex is linked to multiple dimensions of type 1 diabetes heterogeneity, with effects shaped by age, hormonal transitions, genetics, and environment.
- Why it matters: Sex is a critical but understudied contributor to variability in risk, progression, metabolic control, complications, and treatment response.
- What they did: This review synthesises epidemiological, mechanistic, and clinical evidence on how sex relates to disease epidemiology, pathophysiology, presentation, complications, and treatment responses.
- The result: Sex-specific heterogeneity is proposed to inform screening, risk prediction, monitoring, and therapeutic development, and to motivate sex-stratified, hormonally contextualised analyses.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.